◀ Back to FOS

CSF2 — FOS

Pathways - manually collected, often from reviews:

• NCI Pathway Database AP-1 transcription factor network: JUNB/FOS complex (JUNB-FOS) → GM-CSF (CSF2) (transcription, activates) Wang et al., Mol Cell Biol 1994*
  Evidence: reporter gene, physical interaction
• NCI Pathway Database Calcineurin-regulated NFAT-dependent transcription in lymphocytes: JUN/FOS/NFAT1-c-4 complex (FOS-JUN-NFATC1_NFATC2_NFATC3) → GM-CSF (CSF2) (transcription, activates) Cockerill et al., Mol Cell Biol 1995, Tokumitsu et al., Biochem Biophys Res Commun 1993
  Evidence: mutant phenotype, physical interaction
• NCI Pathway Database Calcium signaling in the CD4+ TCR pathway: JUN/FOS/NFAT1-c-4 complex (FOS-JUN-NFATC1_NFATC2_NFATC3) → GM-CSF (CSF2) (transcription, activates) Cockerill et al., Mol Cell Biol 1995, Tokumitsu et al., Biochem Biophys Res Commun 1993
  Evidence: mutant phenotype, physical interaction

Protein-Protein interactions - manually collected from original source literature:

Studies that report less than 10 interactions are marked with *

• IRef Innatedb Interaction: FOS — CSF2 (unknown, -) Thomas et al., Oncogene 1997*
• IRef Innatedb Interaction: FOS — CSF2 (unknown, -) Gramigni et al., FEBS Lett 1998*

Text-mined interactions from Literome

Seppänen et al., Oncol Res 1998 (Adenocarcinoma...) : In the present study, we have investigated the effects of interferons-alpha (IFN-alpha) and -gamma ( IFN-gamma ), interleukin-10 (IL-10) and -13 ( IL-13 ), transforming growth factor-beta1 ( TGF-beta1 ), granulocyte-macrophage colony stimulating factor ( GM-CSF ), and tumor necrosis factor-alpha (TNF-alpha) on cell proliferation and induction of transcription factors AP-1 and NF-kappaB in UM-EC-3 human endometrial adenocarcinoma cells and UT-OC-5 ovarian carcinoma cells in vitro
Matsuo et al., Nihon rinsho. Japanese journal of clinical medicine 2005 : Macrophage colony stimulating factor ( M-CSF ), receptor activator of NF-kappaB ligand ( RANKL ), and other osteoclastogenic ligands activate the NF-kappaB components p50 or p52, the AP-1 component c-Fos , and NFATc1 in osteoclast precursors
Lendemans et al., J Endotoxin Res 2006 : In contrast, the broad-spectrum tyrosine kinase inhibitor genistein and the MEK-1 inhibitor ( PD98059 ) abrogated GM-CSF priming of TNF-alpha release and activation of both NF-kappaB and AP-1
Adunyah et al., J Biol Chem 1991 : We find that GM-CSF stimulates a 2-3-fold increase in chloramphenicol acetyltransferase activity over a concentration range 1-1,000 units/ml. Northern and Western blot analysis demonstrates that the mechanism by which GM-CSF stimulates AP-1 enhancer activity involves increases in c-jun and c-fos mRNA levels, and increases in Jun protein ... These data suggest that the binding of GM-CSF to its receptor stimulates increases in c-jun mRNA and protein and activates AP-1 enhancer activity
Aziz et al., Mol Cell Biol 1999 : Activation of the human colony stimulating factor 1 (CSF-1) receptor in NIH 3T3 cells leads to activation of the mitogen activated protein ( MAP ) kinase pathway and induced expression of c-Fos , c-Myc, and cyclin D1, leading to a potent mitogenic response